{"id":"NCT01318109","sponsor":"Takeda","briefTitle":"Efficacy and Safety of Alogliptin Used Combination With Metformin in Participants With Type 2 Diabetes in Japan","officialTitle":"A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of SYR-322 When Used in Combination With Metformin in Subjects With Type 2 Diabetes in Japan","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2008-08","primaryCompletion":"2009-04","completion":"2009-04","firstPosted":"2011-03-18","resultsPosted":"2011-07-11","lastUpdate":"2012-02-03"},"enrollment":288,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Alogliptin and metformin","otherNames":["SYR-32","Glycoran"]},{"type":"DRUG","name":"Alogliptin and metformin","otherNames":["SYR-322","Glycoran"]},{"type":"DRUG","name":"Metformin","otherNames":["Glycoran"]}],"arms":[{"label":"Alogliptin 12.5 mg QD and metformin 500mg BID or 750mg TID","type":"ACTIVE_COMPARATOR"},{"label":"Alogliptin 25mg QD and metformin 500mg BID or 750mg TID","type":"ACTIVE_COMPARATOR"},{"label":"Metformin 500mg BID or 750mg TID","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study was evaluate the efficacy and safety of alogliptin, once dairy (QD) combined with metformin taken twice daily (BID) or three times daily (TID) in type 2 diabetic patients with uncontrolled blood glucose.","primaryOutcome":{"measure":"Change From Baseline in Glycosylated Hemoglobin (Week 12).","timeFrame":"Baseline and Week 12.","effectByArm":[{"arm":"Alogliptin 12.5 mg QD and Metformin 500mg BID or 750mg TID","deltaMin":-0.54,"sd":0.562},{"arm":"Alogliptin 25mg QD and Metformin 500mg BID or 750mg TID","deltaMin":-0.64,"sd":0.488},{"arm":"Metformin 500mg BID or 750mg TID","deltaMin":0.21,"sd":0.641}],"pValues":[{"comp":"OG000 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null}]},"eligibility":{"minAge":"26 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":92},"commonTop":["Nasopharyngitis","Constipation","Diarrhoea","Headache","Conjunctivitis allergic"]}}